About Enable Medicine
Enable Medicine is a company based in Menlo Park (United States) founded in 2019 by Aaron and Sunil Bodapati. Enable Medicine has raised $63.62 million across 2 funding rounds from investors including Anthos Capital, General Catalyst and Initialized Capital. The company has 44 employees as of December 31, 2022. Enable Medicine offers products and services including Enable Medicine Platform, Biological Atlas, and Actionable Insights Service. Enable Medicine operates in a competitive market with competitors including Genomics, Seven Bridges Genomics, Depixus, Ingenuity Systems and Eagle Genomics, among others.
- Headquarter Menlo Park, United States
- Employees 44 as on 31 Dec, 2022
- Founders Aaron, Sunil Bodapati
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Enable Medicine, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$63.62 M (USD)
in 2 rounds
-
Latest Funding Round
$60 M (USD), Series A
Apr 07, 2022
-
Investors
Anthos Capital
& 7 more
-
Employee Count
44
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enable Medicine
Enable Medicine offers a comprehensive portfolio of products and services, including Enable Medicine Platform, Biological Atlas, and Actionable Insights Service.
Platform integrates biological data for insights in drug discovery and research.
Tool for exploring multimodal data to support therapeutic decision-making.
Service provides AI-driven analysis for patient stratification and target identification.
People of Enable Medicine
Unlock access to complete
Scientist Team
10 people
Leadership Team
2 people
Data Analysis and Operations Team
1 people
CSO Team
1 people
Unlock access to complete
Funding Insights of Enable Medicine
Enable Medicine has successfully raised a total of $63.62M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $60 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Enable Medicine
Enable Medicine has secured backing from 8 investors, including venture fund and angel investors. Prominent investors backing the company include Anthos Capital, General Catalyst and Initialized Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in innovative consumer and technology companies based in Santa Monica.
|
Locked | Locked | Locked | |
|
Investment and transformation services for entrepreneurs in technology and finance sectors.
|
Locked | Locked | Locked | |
|
Seed and early-stage technology investments are managed by the firm.
|
Locked | Locked | Locked |
Investor details for Enable Medicine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Enable Medicine
Investment portfolio details for Enable Medicine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Enable Medicine
Detailed financials for Enable Medicine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enable Medicine Comparisons
Peer comparison for Enable Medicine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enable Medicine
Enable Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genomics, Seven Bridges Genomics, Depixus, Ingenuity Systems and Eagle Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| Locked | Locked | Locked |
Developer of cloud-based software solutions for genomic analysis
|
|
| Locked | Locked | Locked |
Platforms for genomic data analysis and management are provided.
|
Detailed competitors of Enable Medicine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enable Medicine
Complete news archive for Enable Medicine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enable Medicine
Enable Medicine was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Enable Medicine is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Enable Medicine is a funded company, having raised a total of $63.62M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Enable Medicine is 44.
Enable Medicine was established in 2019 and is headquartered in Menlo Park, United States. Drug research and development services are delivered to clients in the pharmaceutical sector. Operations focus on supporting pharmaceutical companies through specialized RD activities. The company is led by co-founders Aaron and Sunil Bodapati. Geographic emphasis remains on the U.S. market, with services tailored to industry needs in drug innovation.
Enable Medicine's top competitors include Eagle Genomics, Depixus and Ingenuity Systems.
Enable Medicine offers Enable Medicine Platform, Biological Atlas, and Actionable Insights Service.
Enable Medicine has 8 investors. Key investors include Anthos Capital, General Catalyst, Initialized Capital, Breyer Capital, and Presight Capital.